Liraglutide

Also called Saxenda, Victoza.

Dr Chad OkayFounder, Suna Health

3 min read. Updated .

Liraglutide is a GLP-1 receptor agonist taken as a daily injection. It is the active drug in Victoza (for type 2 diabetes) and Saxenda (for weight management). It was the first GLP-1 medication approved for weight loss, but weekly newer drugs (semaglutide, tirzepatide) have largely replaced it in new prescriptions because they produce more weight loss with less injecting.

What it does

Liraglutide mimics GLP-1, a hormone the gut releases after meals. It prompts the pancreas to release insulin, slows the rate at which food leaves the stomach, and signals fullness to the brain. Same mechanism as semaglutide, just a much shorter-acting molecule.

Brands

  • Victoza: 1.2 mg or 1.8 mg daily, licensed for type 2 diabetes.
  • Saxenda: up to 3 mg daily, licensed for weight management.
  • Generic liraglutide: now available in some markets after the patent expired.

Liraglutide vs semaglutide

  • Schedule: liraglutide daily, semaglutide weekly.
  • Half-life: liraglutide ~13 hours, semaglutide ~7 days.
  • Average weight loss in trials: 8% for liraglutide 3 mg vs 15% for semaglutide 2.4 mg.
  • Diabetes blood sugar control: in head-to-head trials semaglutide lowered HbA1c (a three-month average of blood sugar) more than liraglutide (SUSTAIN 10), though oral semaglutide was non-inferior to the maximum 1.8 mg liraglutide dose (PIONEER 4).
  • Cost: liraglutide is now the cheaper option in some markets, especially in generic form.

Side effects

  • Nausea, especially in the first month and after each dose increase.
  • Constipation. Slowed gut transit is part of the mechanism.
  • Diarrhoea in a smaller subset, often early.
  • Reflux, burping.
  • Injection-site reactions are more common with daily injecting.
  • Rare but serious: pancreatitis, gallstones, severe gastroparesis. Severe, persistent abdominal pain needs a doctor the same day, not a wait-and-see approach (see below).

Why it's still used

Liraglutide has one of the longest post-launch safety records of any GLP-1 drug, behind only exenatide. It is sometimes preferred when supply of weekly options is unstable, when generic pricing brings the cost down, or when a clinician wants the shorter half-life for taper flexibility. Some people also tolerate the smaller daily peak better than the weekly peak and trough of semaglutide.

If something feels wrong

This entry is reference information, not medical guidance. Your doctor and pharmacist know you and your medicine; if anything about how you feel worries you, speak to them promptly, and if you ever feel seriously unwell, treat it as an emergency. The medicine's own patient information leaflet carries the important safety information and is worth reading in full.

Common questions

Is liraglutide the same as semaglutide?
Same drug class (GLP-1 agonists), different molecules. Liraglutide is shorter-acting and dosed daily. Semaglutide is longer-acting and dosed weekly. Semaglutide produces more weight loss in trials.
Is generic liraglutide as good as branded?
In principle yes, regulatory approval requires bioequivalence. The active drug is identical. Real-world data on generics is still accumulating because they only became available recently.
Why does liraglutide cause nausea more than semaglutide for some people?
The daily peak hits the gut hormone receptors more sharply than the slow weekly rise of semaglutide. Some people find this tolerable, others don't. It's genuinely individual.
Can children take liraglutide?
Yes, in specific cases. Saxenda is approved for adolescents (12 to 17) with obesity and over 60 kg, accessed through specialist paediatric services. Use is rare and supervised.

Sources

Written by Dr Chad Okay. Contributor: Dr Parisah Hussain, MBChB, BSc (Hons), DRCOG, MRCGP. Last updated 17 September 2026. From Digests.

Digests explains how the body works in general, everyday terms. It is not medical advice. It is not a substitute for someone who can examine you and knows your history, and we do not tell you what dose of any medicine to take.

Where we describe how something is checked or looked after, we follow UK guidance from NICE and the NHS. If you are reading this outside the UK, the same concerns are worth taking to your own doctor, though the tests and routes where you live may differ.

Suna Health is building a wearable wellness device for gut health, and you will see it advertised alongside these pages. That commercial interest does not decide what the content says.

If you think we have got something wrong, tell us at digests@suna.health. It goes to the editor. Full terms, including our liability position, are at suna.health/terms.